Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences High Content & Phenotypic Screening 2017

High Content & Phenotypic Screening 2017

Date: Tuesday, 25 April 2017 - Wednesday, 26 April 2017
Location: Holiday Inn, Cambridge, UK


Keynote Speakers

Lorenz Mayr

Lorenz Mayr
Vice President, AstraZeneca Ltd

Leo Price

Leo Price
CEO, Ocello B.V

Jeffrey Morgan

Jeffrey Morgan
Professor of Medical Science and Engineering, Brown University

Overview

This conference brings together researchers from both academia and industry, and will discuss the development of techniques and tools implemented in High Content technologies and Phenotypic Screening applications.

Hot topics to be covered include 3D cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.

Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and government, helping you to find solutions and build collaborations.

Information and local registration facilities for this conference is also available in:

Japanese  |  Korean  |  Chinese(Simplified)  |  Chinese(Traditional) Save

Agenda Topics

  • High Throughput Screening
  • Image Analysis and Data Management
  • Phenotypic and High Content Screening of 3D Models
  • Phenotypic Drug Discovery
  • Phenotypic Screening for New Targets

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Chris Bakal, Dynamical Cell Systems Team Leader, Institute of Cancer Research
Andrew Barlow, Field Application Specialist, Thermo Fisher Scientific
Alexander Baumann, Senior Director, DiscoveRx Corporation
Stephen Brown, RNAi Facility Screening Manager, Sheffield University
Davide Danovi, Director, Kings College London
Anthony Davies, Director of Translational Cell Imaging, The Queensland University of Technology
Roy Edward, Director, Biostatus Ltd
Matthias Fassler, Scientific Account Manager, Genedata
Catherine Goh, Head of Product Development and Marketing, siTOOLs Biotech GmbH
Kamyar Hadian, Group Leader, Helmholtz Zentrum M√ľnchen
Michael Jackson, Senior Vice President, Drug Discovery and Development, Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute
Matthias Nees, Group Leader, University of Turku
Christopher Schofield, Group Leader/Investigator, GlaxoSmithKline
Anton Simeonov, Scientific Director, National Institutes of Health
Jacob Tesdorpf, Director, Perkin Elmer
Bob Van de Water, Professor, Leiden University
Armin Wolf, Professor/Director, Novartis Institutes for BioMedical Research
Wolfram-Hubertus Zimmermann, Professor, University Medical Center Goettingen


Corporate Sponsors Media Sponsors Networking
U-Networks

Add to Calendar ▼2017-04-25 00:00:002017-04-26 00:00:00Europe/LondonHigh Content and Phenotypic Screening 2017High Content and Phenotypic Screening 2017 in Holiday Inn, Cambridge, UKHoliday Inn, Cambridge, UKSELECTBIOenquiries@selectbiosciences.com